NTDs, a group of 21 debilitating infectious diseases, affect over 1 billion people globally, causing significant morbidity, disability, and death. These diseases, including visceral leishmaniasis (VL) ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

A GROUP of parents whose children's deaths were linked to the Dengvaxia vaccine has criticized former Health secretary and ...

While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

Why is there still no dengue vaccine in the country?” This was the question posed by Union of Local Authorities of the Philippines president and Quirino governor Dax Cua to the Department of Health, a ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...

Ecuador's Health Ministry confirmed Thursday that the South American country was going through a dengue epidemic.